Developing a prostate MRI service

The diagnosis of prostate cancer has undergone a paradigm shift in recent years, with MRI now at the forefront of the diagnostic pathway. Several high profile recent trials including the UK-led PROMIS and PRECISION studies have established the performance advantage of MRI over the traditional work-up with systematic transrectal biopsy. Leading on from this, the 2019 NICE guidelines now recommended MRI as the first-line investigation for most men referred with a suspicion of prostate cancer. However, due to a (perhaps deliberate) quirk in the wording of the 2014 edition of the NICE guidelines, a reasoned interpretation meant that the majority of UK centres have already adopted pre-biopsy MRI.

The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.